CD8A and neoplasm: Treatment with the survivin peptide cocktail vaccine was also found to reshape the tumor microenvironment by increasing the tumor infiltration of both CD4+ and CD8+ T cells but not Treg cells, therefore tipping the balance toward a highly efficient immune response [173].